Metabolic changes in early childhood using LCModel with corrected water scaling method

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 1, 2012, Pages 174-180

  Takanashi, Jun Ichi ^a,b   Somazawa, Fuminori ^a   Maruyama, Katsuya ^c   Terada, Hitoshi ^b   Xu, Duan ^d   Barkovich, A James ^d  

^a KAMEDA MEDICAL CENTER   (Japan)

^b TOHO UNIVERSITY   (Japan)

^c Siemens Japan KK   (Japan)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

childhood; correction; LCModel; proton magnetic resonance spectroscopy; water scaling method

Indexed keywords

ADOLESCENT; ARTICLE; BRAIN METABOLISM; CHILD; CONTROLLED STUDY; EPILEPSY; FEBRILE CONVULSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SCANNER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHANTOM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSYCHOMOTOR RETARDATION; WATER SCALING METHOD;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; FOURIER ANALYSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFANT; INFANT, NEWBORN; MAGNETIC RESONANCE SPECTROSCOPY; PHANTOMS, IMAGING; PROTONS; REPRODUCIBILITY OF RESULTS; WATER;

EID: 83755164251     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22802     Document Type: Article

References (13)

1. Danielsen ER, Ross B,. The clinical significance of metabolites. In:, Danielsen ER, Ross B, editors. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York: Marcel Dekker; 1999. p 23-43.
2. van der Knaap MS, Valk J,. Magnetic resonance spectroscopy: basic principles, and application in white matter disease. In, van der Knaap MS, Valk J, editors. Magnetic resonance of myelination and myelin disorders. 3rd edition. Berlin: Springer; 2005. p 859-880.
3. Cecil KM, Kos RS,. Magnetic resonance spectroscopy and metabolic imaging in white matter diseases and pediatric disorders. Top Magn Reson Imaging 2006; 17: 275-293. (Pubitemid 46594177)
4. Brockmann K, Bjornstad A, Dechent P, et al. Succunate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann Neurol 2002; 52: 38-46. (Pubitemid 34693741)
5. Huisman TA, Thiel T, Steinmenn B, Zeilinger G, Martin E,. Proton magnetic resonance spectroscopy of the brain of a neonate with nonketotic hyperglycinemia: in vivo-in vitro (ex vivo) correlation. Eur Radiol 2002; 12: 858-861. (Pubitemid 36940145)
6. Takanashi J, Inoue K, Tomita M, et al. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication. Neurology 2002; 58: 237-241. (Pubitemid 34084213)
7. Provencher SW,. Estimation of metabolite concentrations from localized in vivo NMR spectra. Magn Reson Med 1993; 30: 685-695.
8. Provencher SW,. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264. (Pubitemid 32611437)
9. Provencher SW,. LCModel & LCMgui user's manual. LCModel Version 6.2-4. Available at: http://s-provencher.com/pub/LCModel/manual/manual.pdf. Accessed September 1, 2011.
10. Kreis R, Ernst T, Ross BD,. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993; 30: 424-437. (Pubitemid 23300070)
11. Steen RG, Ogg RJ, Reddick WE, Kingsley PB,. Age-related changes in the pediatric brain: quantitative MR evidence of maturational changes during adolescence. AJNR Am J Neuroradiol 1997; 18: 819-828. (Pubitemid 28529907)
12. Ono J, Kodaka R, Imai K, et al. Evaluation of myelination by T2 value on magnetic resonance imaging. Brain Dev 1993; 15: 433-438. (Pubitemid 24010469)
13. Danielsen ER, Ross B,. Basic physics of MRS. In:, Danielsen ER, Ross B, editors. Magnetic resonance spectroscopy diagnosis of neurological diseases. New York: Marcel Dekker; 1999. p 5-22.